22 Sep 2021 Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer Member news
22 Sep 2021 Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study Member news
17 Sep 2021 Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis Member news
09 Sep 2021 Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases Member news
09 Sep 2021 ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
